Navigation Links
The Veterinary Cooperative (TVC) and Vet-Stem, Inc. Announce an Exclusive Partnership to Offer Regenerative Medicine and Stem Cell Therapy to Over 300 Member Hospitals
Date:8/6/2013

Poway, California (PRWEB) August 06, 2013

The world’s leading Regenerative Veterinary Medicine company out of San Diego California, Vet-Stem, Inc., has entered into an exclusive partnership with The Veterinary Cooperative (TVC) that will allow over 300 member hospitals to immediately start offering Vet-Stem’s stem cell therapy and other Regenerative Veterinary Medicine services. Vet-Stem’s services have been used to treat over 10,000 animals in the last 10 years ranging from horses and dogs, to exotic cats and dolphins. Veterinarians using Vet-Stem cell therapy treat and conduct studies on traumatic and degenerative diseases, including bowed tendons, ligament injuries, osteoarthritis, and osteochondral defects.

“We are incredibly excited and appreciative to have become a long term exclusive provider to one of the country’s premier veterinary cooperatives. TVC is an excellent organization with tremendous leadership and members. Together we will help implement, train and grow the regenerative medicine business in each of the Hospitals associated with TVC. We very much admire the vision of TVC and all of its members in engaging in the future of regenerative medicine as true advanced medicine,” Robert Harman, DVM, CEO of Vet-Stem, Inc.

“After carefully reviewing all regenerative medicine possibilities over the last year we have proudly chosen to incorporate Vet-Stem, Inc. and their regenerative services as our exclusive partner to carry us through the coming years. We believe regenerative medicine is a large part of the future of veterinary medicine. We chose Vet-Stem because they have 10 years in business, 11 peer reviewed papers and have done over 10,000 procedures to date. We feel the quality they can offer is simply unmatched, as well as the fact there is no upfront cost associated with using their industry leading services. We also had a chance to work hand-in-hand with their field services veterinarian who offers excellent in-clinic training, marketing ideas and customer service. We are very excited to now offer Vet-Stem’s services through all of our TVC member hospitals,” Rich Morris, CEO of TVC.

Based in Evanston, Illinois, The Veterinary Cooperative is a member-owned cooperative serving independent veterinarians and animal hospitals nationwide. TVC is managed by professional cooperative personnel and guided by a board of directors elected by and comprised of member/owners. All profits will be returned to TVC member veterinarians in the form of rebate distributions.

About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10999966.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Veterinary Bioscience Institute Responds to Demand by Bringing Back Their Most Popular Webinar Series
2. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
3. The Veterinary Bioscience Institute Announces its Roux-en-Y Gastric Bypass Surgery Model in Rodents
4. The Veterinary Bioscience Institute Announces a Mouse Surgery Webinar Series
5. The Veterinary Bioscience Institute Partners with LabRoots to Produce Laboratory Animal Science BioConference Live
6. Wake Forest Innovations Partners with Veterinary Bioscience Institute to Develop Educational Programs for Life Science Professionals
7. The Veterinary Bioscience Institute Announces its January 2013 Webinar Schedule
8. The Veterinary Bioscience Institute Announces an Amazing Series of 41 Webinars for 2013
9. The Veterinary Bioscience Institute's 2012 Year in Review
10. Veterinary Bioscience Institute (VBI) and a-tune software, Inc. Partnership
11. Pinnaclife Animal Health Features Seal N Heal Wound Shield in New Veterinary Dermatologist Tested and Approved Product Line!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... 27, 2017 , ... The recent vote by the American Medication Association to ... hope to patients and hopefully sheds new light on the way health insurers, governments ... expert and founding partner of Texas Fertility Center . , “This designation ...
(Date:6/27/2017)... ... June 27, 2017 , ... Biodex Medical Systems, Inc. announces the release of ... This assistive aid lifts patients safely from a seated to a standing position without ... Mobility Assist is the latest in a line of Biodex products promoting safe patient ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... its patented GX-1 yeast production and fermentation process. The efficiencies created by ... on micro-organism technologies, most notably the ethanol industry wherein individual production plants are ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... the former Associate Director of Product Development R&D at Allergan and CMC expert ... at both start-up and established biopharma companies, has joined the firm as an ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):